Haemonetics ROA 2010-2025 | HAE
Current and historical return on assets (ROA) values for Haemonetics (HAE) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Haemonetics ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-06-30 | $0.16B | $2.46B | 6.54% |
| 2025-03-31 | $0.17B | $2.45B | 6.65% |
| 2024-12-31 | $0.13B | $2.53B | 5.27% |
| 2024-09-30 | $0.12B | $2.53B | 5.20% |
| 2024-06-30 | $0.11B | $2.54B | 5.10% |
| 2024-03-31 | $0.12B | $2.20B | 5.59% |
| 2023-12-31 | $0.13B | $2.20B | 6.22% |
| 2023-09-30 | $0.13B | $2.01B | 6.58% |
| 2023-06-30 | $0.14B | $1.96B | 7.12% |
| 2023-03-31 | $0.12B | $1.94B | 6.13% |
| 2022-12-31 | $0.10B | $1.88B | 5.17% |
| 2022-09-30 | $0.09B | $1.87B | 4.66% |
| 2022-06-30 | $0.07B | $1.82B | 3.72% |
| 2022-03-31 | $0.04B | $1.86B | 2.42% |
| 2021-12-31 | $0.02B | $1.83B | 1.27% |
| 2021-09-30 | $0.03B | $1.80B | 1.90% |
| 2021-06-30 | $0.07B | $1.79B | 4.09% |
| 2021-03-31 | $0.08B | $1.82B | 5.34% |
| 2020-12-31 | $0.11B | $1.32B | 8.02% |
| 2020-09-30 | $0.11B | $1.42B | 7.99% |
| 2020-06-30 | $0.10B | $1.43B | 7.49% |
| 2020-03-31 | $0.08B | $1.27B | 6.21% |
| 2019-12-31 | $0.08B | $1.24B | 6.45% |
| 2019-09-30 | $0.07B | $1.19B | 5.49% |
| 2019-06-30 | $0.05B | $1.26B | 3.98% |
| 2019-03-31 | $0.06B | $1.28B | 4.39% |
| 2018-12-31 | $0.05B | $1.23B | 3.70% |
| 2018-09-30 | $0.02B | $1.27B | 1.66% |
| 2018-06-30 | $0.02B | $1.24B | 1.74% |
| 2018-03-31 | $0.05B | $1.24B | 3.55% |
| 2017-12-31 | $-0.02B | $1.31B | -1.42% |
| 2017-09-30 | $0.00B | $1.27B | 0.32% |
| 2017-06-30 | $0.00B | $1.25B | 0.31% |
| 2017-03-31 | $-0.03B | $1.24B | -2.00% |
| 2016-12-31 | $0.02B | $1.31B | 1.21% |
| 2016-09-30 | $-0.06B | $1.34B | -4.37% |
| 2016-06-30 | $-0.07B | $1.32B | -4.82% |
| 2016-03-31 | $-0.06B | $1.32B | -4.00% |
| 2015-12-31 | $-0.05B | $1.34B | -3.46% |
| 2015-09-30 | $0.03B | $1.42B | 1.79% |
| 2015-06-30 | $0.02B | $1.43B | 1.36% |
| 2015-03-31 | $0.02B | $1.49B | 1.08% |
| 2014-12-31 | $0.03B | $1.47B | 1.95% |
| 2014-09-30 | $0.03B | $1.48B | 1.95% |
| 2014-06-30 | $0.04B | $1.48B | 2.62% |
| 2014-03-31 | $0.04B | $1.51B | 2.35% |
| 2013-12-31 | $0.04B | $1.49B | 2.57% |
| 2013-09-30 | $0.03B | $1.48B | 2.17% |
| 2013-06-30 | $0.02B | $1.48B | 1.50% |
| 2013-03-31 | $0.04B | $1.46B | 3.01% |
| 2012-12-31 | $0.05B | $1.47B | 3.78% |
| 2012-09-30 | $0.05B | $1.46B | 5.12% |
| 2012-06-30 | $0.06B | $0.93B | 6.84% |
| 2012-03-31 | $0.07B | $0.91B | 7.80% |
| 2011-12-31 | $0.07B | $0.85B | 8.34% |
| 2011-09-30 | $0.07B | $0.82B | 8.75% |
| 2011-06-30 | $0.08B | $0.85B | 9.85% |
| 2011-03-31 | $0.08B | $0.83B | 10.48% |
| 2010-12-31 | $0.06B | $0.78B | 8.46% |
| 2010-09-30 | $0.06B | $0.74B | 8.42% |
| 2010-06-30 | $0.06B | $0.70B | 8.07% |
| 2010-03-31 | $0.06B | $0.76B | 8.09% |
| 2009-12-31 | $0.07B | $0.70B | 9.86% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.651B | $1.361B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.801B | 26.83 |
| Boston Scientific (BSX) | United States | $156.873B | 37.41 |
| Stryker (SYK) | United States | $150.304B | 30.59 |
| EssilorLuxottica (ESLOY) | France | $143.779B | 0.00 |
| Medtronic (MDT) | Ireland | $118.071B | 16.65 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.982B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.547B | 24.90 |
| ResMed (RMD) | United States | $41.283B | 29.52 |
| GE HealthCare Technologies (GEHC) | United States | $33.904B | 15.94 |
| Agilent Technologies (A) | United States | $33.716B | 21.78 |
| Terumo (TRUMY) | Japan | $26.887B | 31.86 |
| Koninklijke Philips (PHG) | Netherlands | $26.663B | 17.64 |
| Insulet (PODD) | United States | $23.536B | 78.86 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.155B | 13.47 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.315B | 0.00 |
| Baxter (BAX) | United States | $12.599B | 9.73 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.925B | 29.11 |
| Lantheus Holdings (LNTH) | United States | $3.865B | 10.45 |
| Envista Holdings (NVST) | United States | $3.530B | 24.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.295B | 14.62 |
| Perrigo (PRGO) | Ireland | $3.287B | 8.21 |
| ICU Medical (ICUI) | United States | $3.126B | 21.28 |
| LeMaitre Vascular (LMAT) | United States | $2.166B | 46.45 |
| Curaleaf Holdings (CURLF) | Canada | $2.148B | 0.00 |
| Acuren (TIC) | United States | $2.126B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.886B | 11.87 |
| Green Thumb Industries (GTBIF) | United States | $1.876B | 80.57 |
| AtriCure (ATRC) | United States | $1.854B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.508B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.305B | 15.41 |
| Neogen (NEOG) | United States | $1.247B | 19.79 |
| AdaptHealth (AHCO) | United States | $1.246B | 17.71 |
| BioLife Solutions (BLFS) | United States | $1.218B | 2543.00 |
| InMode (INMD) | Israel | $0.960B | 8.88 |
| Kestra Medical Technologies (KMTS) | United States | $0.924B | 0.00 |
| Valneva SE (VALN) | France | $0.745B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.699B | 0.00 |
| SNDL (SNDL) | Canada | $0.665B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.611B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.595B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.62 |
| Evolus (EOLS) | United States | $0.490B | 0.00 |
| Surmodics (SRDX) | United States | $0.488B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.475B | 16.36 |
| CeriBell (CBLL) | United States | $0.425B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.380B | 0.00 |
| Owens & Minor (OMI) | United States | $0.378B | 3.35 |
| Canopy Growth (CGC) | Canada | $0.362B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.340B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.302B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.301B | 0.00 |
| High Tide (HITI) | Canada | $0.292B | 0.00 |
| Omeros (OMER) | United States | $0.289B | 0.00 |
| Brainsway (BWAY) | Israel | $0.288B | 58.69 |
| Capricor Therapeutics (CAPR) | United States | $0.286B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 21.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
| Cerus (CERS) | United States | $0.251B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.244B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| Organigram Global (OGI) | Canada | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.214B | 0.00 |
| Exagen (XGN) | United States | $0.210B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 16.34 |
| FitLife Brands (FTLF) | United States | $0.176B | 21.66 |
| Biote (BTMD) | United States | $0.166B | 5.51 |
| Jushi Holdings (JUSHF) | United States | $0.147B | 0.00 |
| Jin Medical (ZJYL) | China | $0.128B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 12.66 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Apyx Medical (APYX) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.10 |
| Zynex (ZYXI) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.051B | 0.00 |
| Veru (VERU) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.75 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.45 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Sharps Technology (STSS) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |